On Pathogens and Persistence Theodor Rosebury reminded us 35 years ago that all life, including microbes, is a single community and that it would be a good idea to stop thinking indiscriminately of our unicellular companions as repulsive, contemptible, or even ferocious (Rosebury, 1969) . Quite appropriately, human medicine (along with granting agencies) demands that we focus on disease and its cure or amelioration. Does this focus sometimes distract us from understanding the biology of the pathogen and the evolution of the host-parasite relationship? One continuing problem facing those of us who study microorganisms that cause human disease is defining exactly what is a pathogen (Falkow, 1997) . Humans live with hundreds of commensal species, along with transient microbes that are "just passing through." Commensals (literally meaning to eat from the same table) inhabit every mucosal nook and cranny, and most are present for our entire lives but do no harm. Meanwhile, pathogens are traditionally defined as organisms that cause disease.
The problem is that the distinction between the commensal and the pathogen can be blurred at times because some commensals cause disease, albeit usually in immunocompromised hosts, whereas some pathogens can persist without causing disease symptoms. Additionally, some of the most well-known pathogens are also arguably members of the indigenous normal flora of our bodies and could be called "commensal pathogens." For example, pneumococcus and meningococcus bacteria regularly inhabit the human nasopharynx and are mostly carried asymptomatically despite the fact that they can cause well-defined diseases. Immunization against these microbes not only protects against disease but also prevents (in an antigen-specific fashion) their ability to colonize the host (reviewed in Segal and Pollard, 2004) . Might the "virulence" determinants that these organisms have in common-such as production of a capsule and an IgA protease-be seen instead as adaptive factors that allow these microbes to occupy a particular niche? Are these organisms simply normal flora that live in a perilous location where they consistently come into contact with elements of the immune system? This brings us back to the difficulty in defining what is a pathogen and what is a commensal. No single, simple definition will include age factors, accidental zoonotic pathogens, and other complicating factors. Yet I take the view that pathogens are best defined by their inherent ability to cross anatomical barriers, inhabit tissue sites, or breach host defenses that ordinarily limit the survival or replication of other microbes and commensals. Furthermore, I believe these invasive properties are essential for the survival of pathogens in nature, and these properties are often associated with clinical disease in some hosts and are frequently host specific. It is not crucial to agree with this definition, but it may put the point of view of this Essay into perspective.
A persistent bacterial infection indicates a longstanding interaction between a microorganism and a host (reviewed in Monack et al., 2004a) . When caused by a pathogen, the initial interaction with the host is usually associated with some degree of tissue invasion and damage. Following this acute phase, those individuals in which a persistent infection develops show little outward signs of disease but, rather, typically act as a reservoir for infection of susceptible individuals through microbial shedding. Persistent infection may be revealed by chronic inflammation, intermittent acute episodes of illness, and sometimes terminal flagrant disease. The best known of the pathogens that cause persistent human infection include Mycobacterium tuberculosis, Chlamydia trachomatis, Treponema pallidum, Salmonella enterica serovar typhi (S. typhi), and Helicobacter pylori-a veritable "who's who" of human death and suffering.
There are a number of experimental questions that face an investigator studying persistent infection. I will use data from our laboratory for H. pylori and Salmonella enterica serovar typhimurium (S. typhimurium) in two models of persistent infection of the laboratory mouse to illustrate just a few of the extraordinary and perhaps unappreciated long-term consequences of an inconspicuous infection on the biology of the host immune system. Persistent Salmonella Infection Salmonella serovars are responsible for human diseases ranging from gastroenteritis to systemic infections. Salmonella gastroenteritis (food poisoning) in humans is an acute, selflimiting infection of the gut mucosa that rarely leads to persistent infection. In contrast, persistent Salmonella infection occurs following systemic infection in which the bacteria breach the mucosal barrier (Monack et al., 2004b) . The ability of Salmonella spp. to cause systemic infection is often host dependent. S. typhi causes a systemic infection, which results in typhoid fever exclusively in humans, whereas S. typhimurium causes systemic infection in mice and some birds but not usually in humans.
During these systemic infections, Salmonella enter the Peyer's patches of the intestinal tract by invading specialized epithelial cells, called M cells. They subsequently target specific types of host cells present in the underlying tissue, such as dendritic cells or macrophages, which traffic through the lymphatic system and bloodstream disseminating the bacteria to the mesenteric lymph nodes (MLNs), spleen, bone marrow, liver, and gall bladder. In a significant proportion of infected individuals, bacteria can persist for life within macrophages in granulomas found in tissue sites, with periodic reseeding of the small intestine, which is associated with fecal shedding and subsequent infection of susceptible individuals in the population.
In mice, a significant component of innate resistance or susceptibility to infection with S. typhimurium, as well as Mycobacterium and Leishmania, is controlled by the gene Nramp1 (Slc11a1), which encodes a proton/divalent-cation antiporter. Expression of Nramp1 is restricted to cells of the monocyte/macrophage lineage and helps the host to control intracellular replication of Salmonella. Historically, Salmonella pathogenesis has been investigated in Nramp1 Asp169 mutant mice, which are highly sensitive to Salmonella infection. Although acute S. typhimurium infections have been well characterized using this model, it is not suitable for studies of long-term carriage. We have studied persistent Salmonella infection using the 129sv mouse strain, which carries the wild-type Nramp1 allele (Monack et al., 2004b) .
Oral S. typhimurium infection of 129sv mice results in systemic infection that, in most cases, does not lead to death of the host. Persistent infection in this model is characterized by sporadic excretion of bacteria in the stool and long-term carriage (>1 year) of S. typhimurium in low numbers within classical granulomatous lesions in the spleen; liver; gall bladder; and, most commonly, MLNs. The microbes persist in this setting despite a robust innate and adaptive immune response.
The initial encounter of 129sv mice with the microbe is not innocuous. The spleen, liver, and MLNs become Shown are hierarchical clusters of gene expression in the peripheral-blood cells of 129sv mice after 10 months of infection with S. typhimurium compared with age-matched uninfected controls. The transcriptional profiles of infected animals (yellow box) and control animals (blue box) cluster separately. The gene cluster showing induced expression in infected mice compared with controls is indicated by the red line, whereas the repressed gene cluster is indicated with a green line. Representative gene ontology categories in each of these clusters are indicated on the right (assessed using DAVID; http://apps1.niaid.nih.gov/david/). Peripheral blood was obtained via retro-orbital bleeds, and RNA was preserved and extracted using the PAXgene Blood RNA Kit (QIAGEN). RNA was amplified using MessageAmp II aRNA Kit (Ambion), labeled during reverse transcription with appropriate Cy dyes, and hybridized to Stanford Functional Genomics Facility murine cDNA microarrays for 48 hr at 65°C. Data were filtered, normalized, and centered, and those genes that changed the most across arrays were retrieved for analysis (3109 genes shown). enormously enlarged because of inflammation and extramedullary hematopoiesis, but by 60 days postinfection (p.i.), there are only minor histological changes in host organs. The number of bacteria is on the order of 1,000-10,000 cfu per gram of tissue as compared with 10 5 -10 7 cfu/g during the acute infection phase. Infected macrophages in the tissues harbor no more than three bacteria each, and fecal shedding of the microbe is sporadic; however, the balance between host and microbe is tenuous. Chronically infected mice (260 days p.i.) treated with an interferon γ (INFγ) neutralizing antibody promptly exhibit symptoms of acute systemic infection with evidence of high levels of bacterial replication in most tissues and high levels of fecal shedding. Thus, INFγ, which is known to affect the level of macrophage activation, plays an essential role in the control of persistent S. typhimurium infection in mice. These data also reveal that, despite a robust adaptive immune response, the host can neither clear the infection nor control acute exacerbations of disease if the host's defenses are compromised even for a relatively brief period of time.
One of the most striking features of this persistent infection can be seen in Figure 1 , which shows the transcriptional profile of peripheral blood taken from mice chronically infected with S. typhimurium for 10 months as compared to age-matched uninfected controls (L.J. Thompson, D. Monack, and S.F., unpublished results). By this time point, although there are low numbers of bacteria in some of the systemic organs, no bacteria can be detected in the blood, and there are no apparent differences in the complete blood count as compared with uninfected controls. Yet this transcriptional profile shows a significant peripheral-blood signature associated with persistent infection, including both up-and downregulated gene clusters. This signature most likely represents an indirect response of the peripheral white blood cells to the infection at tissue sites where the organism is being actively repressed long after any outward signs of disease have diminished. The genes involved include not only factors of the adaptive immune system but also some associated with the innate immune response. Hence, persistent infection may continue for many months, and possibly for a lifetime, constantly modulating the host immune system. Clearly, persistent infection is a dynamic state and not one of quiescent bacteria held in check by the force of the host immune system. Lessons Learned from Persistent H. pylori Infection H. pylori is an important example of a persistent bacterial infection (Blaser and Atherton, 2004; Monack et al., 2004a) . Not only does this bacterium successfully establish itself in the hostile environment of the human stomach, but the infection regularly persists for the lifetime of the host despite an ongoing, vigorous innate and adaptive immune response. In most infected people, H. pylori infection causes a histologically apparent but asymptomatic superficial chronic gastritis. However, significant subsets of infected individuals develop duodenal and peptic ulcers, and 1% of those that are infected will develop adenocarcinoma or mucosal-associated lymphoid tissue (MALT) lymphoma of the stomach.
Most basic research in the Helicobacter field has focused on the study of bacterial virulence determinants and their interaction with gastric epithelial cells. For the purpose of this discussion, I will focus only on one aspect of the interaction between H. pylori and its host. In mouse models of H. pylori, the outcome is closely associated with the genetic background of the host. Balb/c mice infected for 18 months uniformly respond to Helicobacter in exactly the same way as in a small subset of humans (Mueller et al., 2003a) . Direct antigenic stimulation results in the proliferation of lymphocytes and the formation of lymphoid follicles in the gastric mucosa, constituting the MALT. Gastric MALT lymphoma is believed to arise from neoplastic B cell clones in the marginal zone of the follicle that invade the adjacent epithelium, a process marked histologically by the appearance of lymphoepithelial lesions.
In humans, eradication of the bacterium by antibiotic treatment leads to tumor regression in the majority of patients. Consequently, antimicrobial therapy has largely replaced gastric resection as the first line of treatment for MALT lymphoma. We duplicated these findings in the mouse model of infection and followed the subsequent events by immunohistopathology and transcriptional profiling (Mueller et al., 2005) . Tumors regressed in antibiotic-treated mice, and the gastric mucosa returned to a normal architecture; however, there were residual nests of quiescent immune cells in all treated animals. Although these animals had carried Helicobacter for 18 months before treatment and had a strong innate and adaptive immune response to the bacteria, it was possible to easily reinfect these animals. In the reinfected animals, the disease progressed to frank lymphoma in a T cell-dependent, antigen-driven manner much more rapidly. The findings have implications for human therapy but also emphasize that the study of persistent infection provides us with a way to experimentally determine strategies that some bacteria possess for modulating the immune response in order to survive.
It is possible to successfully immunize animals to prevent infection by both Salmonella and H. pylori. In the case of Helicobacter, we found that clusters of T and B cells with intense adipokine staining that reside in the adipose tissue adjacent to the stomach were a hallmark of induced protective immunity (Mueller et al., 2003b) . The continued study of the distinction between priming the immune system to prevent infection and the inability of the immune system to clear the natural infection will prove to be instructive in understanding the biology of both the microbe and the host and will be effective in designing new preventative measures against disease.
Other Lessons from the Study of Persistent Infection Traditionally, we have thought of diseases like typhoid, tuberculosis, and H. pylori-induced ulcers and gastric cancer as diseases to be feared; however, the asymptomatic rate of human infection for each of these organisms is 80% or greater. There is likely to have been a time in the not too distant past when almost all humans were infected by these microbes. Even now, in technologically less advanced countries, these infections are still so common that about 1% of all humans asymptomatically excrete the typhoid bacillus, and 80%-90% are asymptomatically infected with the tubercle bacillus and H. pylori.
One of the consequences of modern medicine and public health in technologically advanced societies is that the carriage rate of H. pylori has fallen dramatically, and, along with it, so have the rate of ulcer disease and the incidence of gastric malignancy. However, it has been pointed out by Martin Blaser and others that, during the same period, the incidence of esophageal cancer has increased remarkably (reviewed in Blaser, 2006; Blaser and Atherton, 2004) . They point to epidemiological evidence that suggests that the presence of H. pylori actually has a protective effect against the incidence of esophageal cancer or that, rather, the loss of H. pylori appears to be one of the factors clearly associated with the massive rise in esophageal diseases. Furthermore, there is a striking inverse relationship between the incidence of prototypical infectious diseases and the incidence of immune disorders (see, for example, Figure 1 in Bach, 2002) . There is also striking experimental evidence from animal models of a causal inverse relationship between infections and allergic or autoimmune diseases. For example, it has been consistently observed that autoimmune diseases in susceptible animals develop earlier and at a higher rate among those bred in a specific-pathogen-free environment as compared to animals bred in a "conventional" environment.
One can argue that organisms like H. pylori, the typhoid bacillus, and perhaps M. tuberculosis have been so common in human populations that they might be considered as part of the normal human flora along with the accepted commensals. If one accepts the idea that H. pylori and other human-adapted "pathogens" are part of our indigenous flora or at least have been our constant companions through human evolution, might they play, overall, a beneficial protective role? Moreover, as they disappear, can we suppose that they are also surrogates for other indigenous microbial species, known and unknown, which are being, and perhaps have been, wiped out by human "progress"? Could this loss be a factor in the appearance of human disease now or in the future?
